Package Leaflets & Bridging Reports: An Overview
In our second piece in a series about package leaflets, we look at consultations with target patient groups and, in particular, bridging reports.
Requirements for a Package Leaflet
“The package leaflet shall reflect the results of consultations with target patient groups to ensure that it is legible, clear and easy to use” (article 59(3)).
In a previous article, we presented one option to meet this requirement which was the submission of a User Test Outcome Report. However, not every package leaflet needs to be subjected to a separate test and alternative evidence may take the format of a Bridging Report.
The term “bridging” is used to describe the situation where, because the leaflets are sufficiently
similar in both content and layout, a successful user consultation on one package leaflet can be used to demonstrate that another package leaflet meets the requirements of Article 59(3).
Bridging will normally be acceptable for package leaflets for medicines in the same therapeutic class where the key safety information is similar. As the design and layout of the information in the package leaflet are crucial to the way in which patients access the key messages for safe use, bridging will be easier to achieve where the package leaflets have a common design, layout, and style of writing.
The main areas to be addressed in a bridging report (comparing the user tested leaflet and the non-user tested leaflet) are;
• Key safety messages
• Design and layout (e.g. font, text size, headings, subheadings)
• The complexity of the messages and the language used
A bridging report may then be presented to the competent authority to meet the requirements of Article 61 (1) “The results of assessments carried out in cooperation with target patient groups shall also be provided to the competent authority.”
We Can Help
We can help your company with package leaflets and bridging reports. Call us today on 00353 52 61 76 706 or complete your details below and we will get back to you.